US EditionSimBioSys Secures Third FDA Clearance for TumorSight™ Viz, Advancing AI-Powered Precision Surgery in Breast Cancer Care
UNITED STATES, JUL 10 – TumorSight Viz reduces breast cancer surgery re-excision rates above 20% by providing AI-driven 3D MRI visualizations for improved surgical precision, clinical data shows.
- On July 9, 2025, in Chicago, SimBioSys announced that its TumorSight Viz platform received a third regulatory clearance from the FDA, introducing version 1.3 with advanced AI features that improve surgical planning for breast cancer.
- This clearance follows clinical evidence showing wide variability in surgical decisions and rising needs for standardized, precision-guided breast cancer surgery.
- TumorSight Viz 1.3 transforms conventional breast MRI scans into detailed three-dimensional models, enhancing accuracy, ease of use, and seamless integration within surgical workflows to aid personalized surgical planning.
- Barry Rosen, MD, stated that TumorSight Viz 1.3 enhances surgeons' ability to clearly understand anatomical details during breast cancer surgery, enabling more precise decision-making.
- The clearance strengthens SimBioSys’s commitment to improving patient outcomes by enabling more precise, consistent, and confident breast cancer surgery aligned with modern care standards.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
All
Left
1
Center
11
Right
OSS Announces $2 Million Follow-On Production Order from Innovative Medical Imaging OEM - One Stop Systems (NASDAQ:OSS)
ESCONDIDO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (NASDAQ:OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced a new $2 million production contract from a breakthrough medical imaging OEM advancing non-invasive breast cancer screening. OSS expects the total program value of at least $25 million ov…
·New York, United States
Read Full Article
Coverage Details
Total News Sources23
Leaning Left1Leaning Right0Center11Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
